Transfusion - Pre-compatibility Testing —
Training activity: 8

Details

Produce a transfusion management plan for patients with a haemoglobinopathy

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Challenges associated with blood provision
  • Multiple antibodies
  • Antibodies to high frequency antigen
  • Imbalance between donor and patient ethnicity and antigen frequency
• Special requirements for transfusion of haemoglobinopathy patients for
  • Top up transfusions
  • Exchange
  • Pre surgery

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• How does producing a transfusion management plan for patients with a haemoglobinopathy fit into the broader context of pre-compatibility testing and patient care?
• What are the relevant national and local guidelines for transfusion support in patients with haemoglobinopathies (e.g., sickle cell disease, thalassaemia)?
• What are the typical transfusion requirements and potential complications (e.g., alloimmunisation, hyperviscosity) in these patient groups?
• What specific blood components are typically indicated and what special requirements might they have (e.g., extended phenotype matching)?
• What clinical information is essential to consider when developing a transfusion management plan (e.g., patient history, clinical status, previous transfusion reactions, antibody history)?
• Consider the specific insights you hope to gain into the complexities of providing transfusion support for patients with haemoglobinopathies.
• Think about your current knowledge of different haemoglobinopathies and their associated transfusion challenges and where you want to deepen your understanding.
• Review relevant guidelines, protocols, and case histories related to transfusion in haemoglobinopathies.
• Consider potential challenges such as managing patients with multiple alloantibodies or determining appropriate transfusion triggers, and think about how to approach these.
• Reflect on your current understanding of patient blood management principles in the context of chronic transfusion requirements.

In action

• What information are you prioritising as you gather the necessary data to create the transfusion management plan (e.g., patient history, previous transfusions, antibody screen results, clinical status)? Why are you focusing on these specific aspects?
• What decisions are you making as you formulate the plan (e.g., frequency of transfusion, target haemoglobin levels, component selection, need for extended matching)?
• How effectively are you integrating the available information to develop a comprehensive and safe transfusion management plan?
• What challenges are you facing as you try to balance the patient’s needs with available resources and potential risks (e.g., managing alloimmunisation, iron overload)?
• How does this planning activity connect to your understanding of the overall care of patients with haemoglobinopathies and the role of transfusion support?
• Are there alternative management strategies you should consider based on the patient’s specific circumstances or any new information that arises3?
• What support or guidance might you need from senior colleagues or clinical guidelines to ensure the plan is appropriate and safe?
• Are you ensuring that the proposed plan aligns with current best practices and local protocols?

On action

• What were the key factors you considered when developing the transfusion management plan for the patient with a haemoglobinopathy (e.g., patient history, previous transfusion reactions, antibody status)?
  • What were the main components of the plan you produced (e.g., frequency of transfusion, component selection)?
  • What information was most critical in guiding your decision-making process?
  • Were there any gaps in the information available?
  • How did your reflect-in-action (e.g., your approach to gathering information, your initial considerations) shape the final transfusion management plan?
• What skills or knowledge did you develop or improve related to understanding the specific transfusion requirements of patients with haemoglobinopathies and formulating appropriate management plans?
  • Were there any challenges or complexities in this specific case that broadened your understanding of the factors influencing transfusion decisions in this patient group?
  • How does this experience connect to the overarching goals of transfusion support for patients with haemoglobinopathies, such as preventing complications and improving quality of life?
• What areas for continued development have you identified in your ability to create comprehensive transfusion management plans for patients with haemoglobinopathies?
  • How will you apply the learning from this experience to future cases, ensuring you consider the specific needs and potential complications associated with haemoglobinopathies?
  • What further learning or resources would be beneficial for your ongoing development in this area, such as reviewing relevant guidelines or discussing cases with experienced colleagues?
  • What actions / ‘next steps’ will you take to solidify your understanding and improve your skills in this aspect of transfusion practice?

Beyond action

• Have you been involved in developing other transfusion management plans for patients with different haemoglobinopathies (e.g., sickle cell disease, thalassaemia) since this training activity? How did the specific requirements differ?
• What additional factors would you now consider when creating such a plan based on your subsequent learning?
• Have you encountered clinical scenarios where the transfusion management of a patient with a haemoglobinopathy needed to be adapted due to unexpected events or complications? How did your initial planning compare to the actual management? Have you discussed these scenarios with colleagues?
• Has this training activity improved your understanding of the long-term transfusion needs and potential complications in patients with haemoglobinopathies?
• Do you now have a better appreciation for the importance of considering factors such as red cell antibodies, iron overload, and transfusion reactions when planning long-term transfusion support?
• Has this experience influenced your ability to communicate effectively with clinical teams about the specific transfusion requirements of these patients?
• How will your experience in creating transfusion management plans for patients with haemoglobinopathies prepare you for contributing to multidisciplinary team meetings and developing comprehensive care pathways for these patients?
• Will your knowledge in this area be valuable in understanding and implementing national guidelines for the transfusion management of haemoglobinopathies?
• How might this experience support your potential involvement in audit or research activities related to transfusion outcomes in this patient group?

Relevant learning outcomes

#	Outcome
# 1	Outcome Select suitable and valid techniques for transfusion pre-compatibility testing.
# 2	Outcome Identify sequential testing algorithms appropriate to the samples under investigation for pre-compatibility testing.
# 3	Outcome Describe the limitations of methods used in pre-compatibility testing including sources of error and sample issues.
# 4	Outcome Practice in accordance with guidelines and procedures relevant to pre-transfusion testing.
# 5	Outcome Perform acceptance testing of samples requiring pre-transfusion testing and ensure samples follow appropriate testing streams relating to clinical condition.
# 6	Outcome Perform phenotyping and/or referral of genotyping to complete investigation for pre-transfusion testing.
# 7	Outcome Propose resolutions for anomalous blood group antigen typing.
# 8	Outcome Devise and perform investigative strategies for complex antibody identifications and transfusion reaction investigations.
# 9	Outcome Identify transfusion requirements and create management plans for patients following completion of all pre-compatibility investigations.